Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
87.20%
Operating Margin
49.04%
Net Margin
32.37%
Efficiency Metrics
Revenue per Expense Ratio
1.96
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
76.96%
Income Tax Rate
0.00%
EPS
1.1600000000
Balance Sheet Analysis
Current Ratio
2.93
Cash Ratio
0.04
Working Capital
$157.48M
Debt to Equity
0.81
Debt to Assets
42.40%
Equity Ratio
52.44%
Cash Flow Analysis
Operating Cash Flow Ratio
56.66%
Free Cash Flow Ratio
56.49%
CapEx to Revenue
0.17%
Dividends Paid
$86.96M
Stock Buybacks
$1.00M
Total Shareholder Returns
$87.97M
Cash Position Change
-53.01%
Key Takeaways (2023 FY)
Increased dividend payments by 3.81%
Detailed Growth Metrics
Core Performance
Revenue
12.23%
Net Income
-33.20%
EPS
-38.30%
Operating Income
-22.29%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
15.10%
Operating Cash Flow
13.12%
Free Cash Flow
12.79%
Balance Sheet Health
Assets
16.64%
Debt
8.08%
Book Value per Share
17.48%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
3.81%
Shares Outstanding
7.04%
Long Term Trends
3Y Revenue/Share
6.01%
5Y Revenue/Share
9.66%
3Y Dividend/Share
16.71%
5Y Dividend/Share
38.29%